ALNY
Alnylam Pharmaceuticals Inc
NASDAQ: ALNY · HEALTHCARE · BIOTECHNOLOGY
$309.49
+2.76% today
Updated 2026-04-30
Market cap
$40.19B
P/E ratio
129.82
P/S ratio
10.82x
EPS (TTM)
$2.32
Dividend yield
—
52W range
$246 – $496
Volume
1.1M
Alnylam Pharmaceuticals Inc (ALNY) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-24.63M | $196.52M | $65.49M | $-72.14M | $-84.34M | $-87.07M | $-115.61M | $-68.66M | $-165.64M | $-189.14M | $-307.70M | $-382.79M | $-562.62M | $-278.43M | $-614.96M | $-641.69M | $-541.27M | $104.16M | $-8.31M | $524.08M |
| Capital expenditures | $4.99M | $7.79M | $10.76M | $4.95M | $4.73M | $1.29M | $8.35M | $4.01M | $8.96M | $12.95M | $64.56M | $104.21M | $126.89M | $140.16M | $70.36M | $76.37M | $72.06M | $62.21M | $34.28M | $58.70M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $8.30M | $14.47M | $18.03M | $20.17M | $19.34M | $16.80M | $12.36M | $20.70M | $33.06M | $45.78M | $75.53M | $92.82M | $157.75M | $174.84M | $139.87M | $165.72M | $230.65M | $221.68M | $272.08M | $348.24M |
| Free cash flow | $-29.62M | $188.73M | $54.73M | $-77.09M | $-89.07M | $-88.36M | $-123.96M | $-72.66M | $-174.60M | $-202.09M | $-372.26M | $-487.00M | $-689.50M | $-418.58M | $-685.32M | $-718.07M | $-613.33M | $41.95M | $-42.59M | $465.38M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | $-62.87M | $-4.37M | $-18.82M | $1.76M | $22.01M | $105.72M | $12.72M | $451.74M | $-224.20M | $127.08M | $-55.50M | $332.13M | $53.83M | — | — | — |